The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths in the US, and it is expected to be the second leading cause of cancer deaths by 2030.The lack of effective early Serving Bowl screening tests and alarming symptoms with early undetectable micro-metastasis at the time of presentation play a vital role in the high d

read more